Lockheed Martin Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Lockheed Martin Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Sell	3,200 -340	-10%	-$231K	0.08%	106
2026 Q1	$2.74M	Buy	3,540 +40	+1%	+$30.6K	0.1%	94
2025 Q4	$2.7M	Buy	+3,500	New	+$2.38M	0.09%	87
2016 Q2	–	Sell	-2,000	Closed	-$721K	–	116
2016 Q1	$721K	Sell	2,000 -1,575	-44%	-$649K	0.07%	68
2015 Q4	$1.94M	Sell	3,575 -4,000	-53%	-$2.17M	0.18%	45
2015 Q3	$3.52M	Hold	7,575	–	–	0.4%	36
2015 Q2	$3.86M	Buy	7,575 +2,075	+38%	+$1.01M	0.19%	54
2015 Q1	$2.48M	Buy	5,500 +4,500	+450%	+$1.91M	0.12%	72
2014 Q4	$410K	Buy	+1,000	New	+$393K	0.02%	109

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Lockheed Martin Investment Management's REGN Position: Q2 2026 in Review

Lockheed Martin Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 9.6% in Q2 2026, selling an estimated $231K and leaving 3,200 shares worth $2M. The position accounts for 0.08% of the portfolio, ranked #106.

Lockheed Martin Investment Management first reported a position in REGN in Q4 2014 and has held it in 9 quarters since. The position peaked at $3.86M in Q2 2015. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Lockheed Martin Investment Management held 3,200 shares of Regeneron Pharmaceuticals worth $2M as of Q2 2026.
Lockheed Martin Investment Management sold 340 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $231K.
Regeneron Pharmaceuticals made up 0.08% of Lockheed Martin Investment Management's portfolio in Q2 2026, its #106 holding.
Lockheed Martin Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 9 quarters since.
Lockheed Martin Investment Management's Regeneron Pharmaceuticals position peaked at $3.86M in Q2 2015.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.